Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 11, Issue 12

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Investigational Drugs, Volume 11, Issue 12 (2002)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Investigational Drugs, Volume 11, Issue 12 (2002)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Volume 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Review

Review Article

Histone deacetylase inhibitors: from target to clinical trials

William K Kelly, Owen A O’Connor & Paul A Marks

Pages: 1695-1713

Published online: 24 Feb 2005

AbstractforHistone deacetylase inhibitors: from target to clinical trials | References | PDF (252.1 KB)

298 Views
200 CrossRef citations
0Altmetric

Review Article

Therapies directed at vascular endothelial growth factor

Paul W Manley, Georg Martiny-Baron, Jean-Marc Schlaeppi & Jeanette M Wood

Pages: 1715-1736

Published online: 24 Feb 2005

AbstractforTherapies directed at vascular endothelial growth factor | References | PDF (371.3 KB)

159 Views
77 CrossRef citations
0Altmetric

Review Article

Pharmacological treatments for prostate cancer

Janet R Walczak & Michael A Carducci

Pages: 1737-1748

Published online: 24 Feb 2005

AbstractforPharmacological treatments for prostate cancer | References | PDF (192.5 KB)

56 Views
8 CrossRef citations
0Altmetric

Review Article

Cyclooxygenase 2 selective inhibitors in cancer treatment and prevention

David G Menter

Pages: 1749-1764

Published online: 24 Feb 2005

AbstractforCyclooxygenase 2 selective inhibitors in cancer treatment and prevention | References | PDF (2.3 MB)

30 Views
8 CrossRef citations
0Altmetric

Review Article

The α_v integrin antagonists as novel anticancer agents: an update

Janet S Kerr, Andrew M Slee & Shaker A Mousa

Pages: 1765-1774

Published online: 24 Feb 2005

AbstractforThe α_v integrin antagonists as novel anticancer agents: an update | References | PDF (149.1 KB)

105 Views
45 CrossRef citations
0Altmetric

Review Article

Future potential of thymidylate synthase inhibitors in cancer therapy

Norman L Lehman

Pages: 1775-1787

Published online: 24 Feb 2005

AbstractforFuture potential of thymidylate synthase inhibitors in cancer therapy | References | PDF (227.4 KB)

177 Views
34 CrossRef citations
0Altmetric

Review Article

Developing therapeutic pharmaceuticals for the treatment of soft-tissue sarcomas

Shreyaskumar R Patel

Pages: 1789-1793

Published online: 24 Feb 2005

AbstractforDeveloping therapeutic pharmaceuticals for the treatment of soft-tissue sarcomas | References | PDF (89.3 KB)

37 Views
1 CrossRef citations
0Altmetric

Review Article

Novel therapies for sepsis: antiendotoxin therapies

Sanjay Manocha, Daniel Feinstein, Aseem Kumar & Anand Kumar

Pages: 1795-1812

Published online: 24 Feb 2005

AbstractforNovel therapies for sepsis: antiendotoxin therapies | References | PDF (303.4 KB)

145 Views
39 CrossRef citations
0Altmetric

Review Article

Therapies in development for the treatment of migraine

Hermann Mucke

Pages: 1813-1820

Published online: 24 Feb 2005

AbstractforTherapies in development for the treatment of migraine | References | PDF (134 KB)

38 Views
2 CrossRef citations
0Altmetric

Review Article

Novel therapies for narcolepsy

Stephen Brooks & Jed Black

Pages: 1821-1827

Published online: 24 Feb 2005

AbstractforNovel therapies for narcolepsy | References | PDF (109.4 KB)

55 Views
2 CrossRef citations
0Altmetric

Drug Evaluation

Article

Metvan: a novel oxovanadium(IV) complex with broad spectrum anticancer activity

Osmond J D’Cruz & Fatih M Uckun

Pages: 1829-1836

Published online: 24 Feb 2005

AbstractforMetvan: a novel oxovanadium(IV) complex with broad spectrum anticancer activity | References | PDF (135.4 KB)

144 Views
87 CrossRef citations
0Altmetric

Article

Enfuvirtide

Ray Y Chen, J Michael Kilby & Michael S Saag

Pages: 1837-1843

Published online: 24 Feb 2005

AbstractforEnfuvirtide | References | PDF (188.9 KB)

213 Views
34 CrossRef citations
0Altmetric

Article

Review of the proliferation inhibitor everolimus

Björn Nashan

Pages: 1845-1857

Published online: 24 Feb 2005

AbstractforReview of the proliferation inhibitor everolimus | References | PDF (214.8 KB)

449 Views
98 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Inflammation and Huntington’s disease- a neglected therapeutic target?

Sophie E. Field et al.

Review Article | Published online: 17 May 2024

Drugs in preclinical and early clinical development for the treatment of Chagas´s disease: the current status

Fernanda Karoline Vieira da Silva Torchelsen et al.

Review Article | Published online: 14 May 2024

Emerging therapies for overactive bladder: preclinical, phase I and phase II studies

Samantha Gibson et al.

Review Article | Published online: 9 May 2024

Frontotemporal dementia: from genetics to therapeutic approaches

Francesca R. Buccellato et al.

Review Article | Published online: 9 May 2024

Open Access

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.11, Iss.12, 2002)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?